PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases

HO Alsaab, FD Alharbi, AS Alhibs, NB Alanazi… - Pharmaceutics, 2022 - mdpi.com
Research on the use of biodegradable polymers for drug delivery has been ongoing since
they were first used as bioresorbable surgical devices in the 1980s. For tissue engineering …

Nanotherapeutics for nose-to-brain drug delivery: an approach to bypass the blood brain barrier

D Lee, T Minko - Pharmaceutics, 2021 - mdpi.com
Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders
has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits …

Controlled release and targeted drug delivery with poly (lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

A Zeb, M Gul, TTL Nguyen, HJ Maeng - Journal of Pharmaceutical …, 2022 - Springer
Background Controlled release and targeted delivery of the drug payload are the two most
fascinating applications of nanoparticle-based systems explored in the recent past. The …

Recent expansions of novel strategies towards the drug targeting into the brain

A Alexander, M Agrawal, A Uddin… - International journal …, 2019 - Taylor & Francis
The treatment of central nervous system (CNS) disorders always remains a challenge for the
researchers. The presence of various physiological barriers, primarily the blood–brain …

Blood–brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders

HK Alajangi, M Kaur, A Sharma, S Rana, S Thakur… - Molecular Brain, 2022 - Springer
The integrity of the blood–brain barrier (BBB) is essential for normal central nervous system
(CNS) functioning. Considering the significance of BBB in maintaining homeostasis and the …

[HTML][HTML] Intranasal polymeric and lipid-based nanocarriers for CNS drug delivery

R Maher, A Moreno-Borrallo, D Jindal, BT Mai… - Pharmaceutics, 2023 - mdpi.com
Nanomedicine is currently focused on the design and development of nanocarriers that
enhance drug delivery to the brain to address unmet clinical needs for treating …

Advanced particulate carrier-mediated technologies for nasal drug delivery

VP Chavda, G Jogi, N Shah, MN Athalye… - Journal of Drug Delivery …, 2022 - Elsevier
Nasal drug delivery has been employed as an alternate and convenient route for the
systemic availability of pharmaceuticals, particularly for potent therapeutics. This is owing to …

Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine

S Sharma, A Tyagi, S Dang - International Journal of Biological …, 2023 - Elsevier
The present work focuses on the development of surface modified transferrin PLGA
nanoparticles loaded with clonidine for nose to brain delivery. The CLD-Tf-PLGA-NPs were …

Targeting fibronectin to overcome remyelination failure in multiple sclerosis: the need for brain-and lesion-targeted drug delivery

PEM van Schaik, IS Zuhorn, W Baron - International Journal of Molecular …, 2022 - mdpi.com
Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease with
unknown etiology that can be characterized by the presence of demyelinated lesions …

[HTML][HTML] A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation

H Akel, R Ismail, G Katona, F Sabir, R Ambrus… - International Journal of …, 2021 - Elsevier
With the increasingly widespread of central nervous system (CNS) disorders and the lack of
sufficiently effective medication, meloxicam (MEL) has been reported as a possible …